Skip to Content

Rosenbluh lab publications

Selected highlight publications

1. Rosenbluh J, Xu H, Harrington W, Gill S, Wang X, Vazquez F, Root DE, Tsherniak A, Hahn WC. 2017. Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression. Nature Communications, 8:15403.

2. Rosenbluh J, Mercer J, Shrestha Y, Oliver R, Tamayo P, Doench JG, Piccioni F, Horn H, Fagbami L, Yang-Zho D, Perrimon N, Jaffe J, Lage K, Boehm JS, Hahn WC. 2016. Integrated genetic and proteomic interrogation of WNT/β-catenin cancer dependencies. Cell Systems, 3(3):302-316.

3. Kim JW, Botvinnik OB, Abudayyeh O, Birger C, Rosenbluh J, Shrestha Y, Abazeed ME, Hammerman PS, DiCara D, Konieczkowski DJ, Johannessen CM, Liberzon A, Alizad-Rahvar AR, Alexe G, Aguirre A, Ghandi M, Greulich H, Vazquez F, Weir BA, Van Allen EM, Tsherniak A, Shao DD, Zack TI, Noble M, Getz G, Beroukhim R, Garraway LA, Ardakani M, Romualdi C, Sales G, Barbie DA, Boehm JS, Hahn WC, Mesirov JP, Tamayo P. 2016. Characterizing genomic alterations in cancer by complementary functional associations. Nature Biotechnology, 34(5):539-546.

4. Giannakis M, Hodis E, Mu J, Yamauchi M, Rosenbluh J, Cibulskis K, Saksena G, Lawrence MS, Van Allen EM, Hahn WC, Gabriel SB, Lander ES, Getz G, Ogino S, Fuchs CS, Garraway LA. RNF43 is frequently mutated in colorectal and endometrial cancers. 2014, RNF43 is frequently mutated in colorectal and endometrial cancers. Nature Genetics, 46:1264-66.

5. Rosenbluh J, Wang X, Hahn WC. 2014. Genomic insights into WNT/β-catenin signaling. Trends in Pharmacological Science, 35(2):103-9.

6. Shao DD, Xue W, Krall, EB, Bhutkar A, Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim WJ, Zwang Y, Root DE, Jacks T, Hahn WC. 2014. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell, 158(1):171-184.

7. Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak T, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC. 2012. β-catenin driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell, 151(7):1457-1473

8. Nijhawan D, Zack TI, Ren Y, Strickland MR, Lamothe R, Schumacher SE, Tsherniak A, Besche HC, Rosenbluh J, Shehata S, Cowley GS, Weir BA, Goldberg AL, Mesirov JP, Root DE, Bhatia SN, Beroukhim R, Hahn WC. Cancer vulnerabilities unveiled by genomic loss. 2012, Cancer vulnerabilities unveiled by genomic loss. Cell, 150(4): 842-54.

Additional publications

A full list of Rosenbluh Lab publications can be viewed on PubMed.